Cargando…

The Pharmacological Shock Treatment of Schizophrenia

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Thacker 1938
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5219442/

Ejemplares similares

Pharmacologic Treatment Options for Insomnia in Patients with Schizophrenia
por: Stummer, Lauren, et al.
Publicado: (2018)

Pharmacologic treatment of schizophrenia
por: Kane, John M., et al.
Publicado: (2010)

Cigarette Smoking and Schizophrenia: Etiology, Clinical, Pharmacological, and Treatment Implications
por: Ding, Jack Baichao, et al.
Publicado: (2021)

Cariprazine, A Broad-Spectrum Antipsychotic for the Treatment of Schizophrenia: Pharmacology, Efficacy, and Safety
por: Laszlovszky, István, et al.
Publicado: (2021)

Avolition as the core negative symptom in schizophrenia: relevance to pharmacological treatment development
por: Strauss, Gregory P., et al.
Publicado: (2021)

Holistic Management of Schizophrenia Symptoms Using Pharmacological and Non-pharmacological Treatment
por: Ganguly, Pronab, et al.
Publicado: (2018)

Pharmacological Treatment of Schizophrenia: Japanese Expert Consensus
por: Sakurai, Hitoshi, et al.
Publicado: (2021)

Brexpiprazole—Pharmacologic Properties and Use in Schizophrenia and Mood Disorders
por: Siwek, Marcin, et al.
Publicado: (2023)

Effects of Adherence to Pharmacological Treatment on the Recovery of Patients with Schizophrenia
por: Caqueo-Urízar, Alejandra, et al.
Publicado: (2021)

Negative and Cognitive Symptoms of Schizophrenia: Are there Adequate Pharmacological Treatments?
por: Vasiliu, O.
Publicado: (2022)

Addressing the unmet needs of patients with persistent negative symptoms of schizophrenia: emerging pharmacological treatment options
por: Chue, Pierre, et al.
Publicado: (2014)

Tackling HIV Persistence: Pharmacological versus CRISPR-Based Shock Strategies
por: Darcis, Gilles, et al.
Publicado: (2018)

The role of shared decision-making in improving adherence to pharmacological treatments in patients with schizophrenia: a clinical review
por: Fiorillo, Andrea, et al.
Publicado: (2020)

Non-pharmacological treatments for schizophrenia in Southeast Europe: An expert survey
por: Stevović, Lidija Injac, et al.
Publicado: (2021)

A new generation of antipsychotics: pharmacology and clinical utility of cariprazine in schizophrenia
por: Caccia, Silvio, et al.
Publicado: (2013)

The Shock of the New: Progress in Schizophrenia Genomics
por: Moore, Susan, et al.
Publicado: (2011)

The Treatment of Shock
Publicado: (1943)

Is pharmacological intervention necessary in prodromal schizophrenia?
por: Zhao, Jingping, et al.
Publicado: (2012)

Evidence-Based Recommendations for the Pharmacological Treatment of Women with Schizophrenia Spectrum Disorders
por: Brand, Bodyl A., et al.
Publicado: (2023)

Heat Shock Proteins and Autophagy Pathways in Neuroprotection: From Molecular Bases to Pharmacological Interventions
por: Penke, Botond, et al.
Publicado: (2018)

Cost-effectiveness of pharmacological and psychosocial interventions for schizophrenia
por: Phanthunane, Pudtan, et al.
Publicado: (2011)

Pharmacological treatment of negative symptoms in schizophrenia: update and proposal of a clinical algorithm
por: Cerveri, Giancarlo, et al.
Publicado: (2019)

The PI3K signaling pathway as a pharmacological target in Autism related disorders and Schizophrenia
por: Enriquez-Barreto, Lilian, et al.
Publicado: (2016)

Treatment of Schizophrenia by Inducing Epileptiform Shocks by the Drug Cardiazol: An Experimental Study of 42 Cases
por: Dhunjibhoy, J. E.
Publicado: (1938)

Pharmacological Treatment in Presbyopia
por: Grzybowski, Andrzej, et al.
Publicado: (2022)

The medical treatment of cardiogenic shock
por: Lescroart, Mickael, et al.
Publicado: (2023)

Clinical pharmacology study of cariprazine (MP-214) in patients with schizophrenia (12-week treatment)
por: Nakamura, Tadakatsu, et al.
Publicado: (2016)

The More, the Merrier…? Antipsychotic Polypharmacy Treatment Strategies in Schizophrenia From a Pharmacology Perspective
por: Hjorth, Stephan
Publicado: (2021)

Pharmacological Augmentation of Psychosocial and Remediation Training Efforts in Schizophrenia
por: Harvey, Philip D., et al.
Publicado: (2017)

Japanese Society of Neuropsychopharmacology: “Guideline for Pharmacological Therapy of Schizophrenia”
Publicado: (2021)

Pharmacotherapy for treatment-resistant schizophrenia
por: Mcilwain, Meghan E, et al.
Publicado: (2011)

Profile of blonanserin for the treatment of schizophrenia
por: Tenjin, Tomomi, et al.
Publicado: (2013)

Current Concepts and Treatments of Schizophrenia
por: Stępnicki, Piotr, et al.
Publicado: (2018)

The role of lumateperone in the treatment of schizophrenia
por: Syed, Alveena Batool, et al.
Publicado: (2021)

Pharmacological and Non-pharmacological Treatments for Stroke Prevention in Patients with Atrial Fibrillation
por: Ueberham, Laura, et al.
Publicado: (2017)

Pharmacological and Non-Pharmacological Treatments for Depression in Parkinson’s Disease: An Updated Review
por: Angelopoulou, Efthalia, et al.
Publicado: (2023)

Pharmacological treatments of COVID-19
por: Sahebnasagh, Adeleh, et al.
Publicado: (2020)

The Pharmacological Treatment of Pediatric Vertigo
por: Viola, Pasquale, et al.
Publicado: (2022)

The Efficacy of Non-Pharmacological Interventions on Brain-Derived Neurotrophic Factor in Schizophrenia: A Systematic Review and Meta-Analysis
por: Sanada, Kenji, et al.
Publicado: (2016)

Vasoactive pharmacologic therapy in cardiogenic shock: a critical review
por: Kaddoura, Rasha, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_iqknivklgmbhepi8qlsj76klnn